Seeking Alpha

Oxygen Biotherapeutics takes a break, OXiGENE goes parabolic

  • Shares of Oxygen Biotherapeutics (OXBT -5%) are taking a breather today (perhaps we should call it a well-deserved rest) after running up over 300% in five sessions.
  • Incidentally, MarketWatch has picked up on the recent rally, noting that OXBT "could have been considered a penny stock [last week] with shares trading under $2" before the levosimendan news helped the stock "more than quintuple."
  • Meanwhile, shares of similarly-named OXiGENE (OXGN +74.4%) are staging a fantastic rally, on volume of 9.2M versus a 10-day average of just 55K. Here's SA contributor PropThink: "Now we're just walking backwards through the NASDAQ listings."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs